eo adjuvant chemotherapy by Docetaxel + S-1 for resentable gasric cabcer
Not Applicable
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000015632
- Lead Sponsor
- Department of Frontier Surgery, Graduate school of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active double cancer. 2. Administration contraindication of TS-1 3. Continuous use of flucytosine, phenytoin or warfarin potassium 4. History of severe drug allergy (over grade 3) 5. Severe complications 6. infection or acute infectious disease 7. HBV or HCV positive 8. Severe watery diarrhea 9. Female who are pregnant, nursing, suspected of being pregnant or hope to become pregnant during the study period. 10. No birth-control 11. Psychosis or Psychiatric disorder 12. Sever edema to treat 13. History of severe peripheral nerve disorder (over grade 2) 14. HIV positive 15. Patients judged inappropriate for the study by their physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method feasibility
- Secondary Outcome Measures
Name Time Method